Search research articles
Contact Us
Filters
Showing results (151-160 of 184) with videos related to
Page
of 19
Sort By:
British Journal of Clinical Pharmacology
|
December 2, 2017
Prediction of olanzapine exposure in individual patients using physiologically based pharmacokinetic modelling and simulation
Thomas M Polasek, Geoffrey T Tucker, Michael J Sorich, et al.
Pharmaceutics
|
January 21, 2022
Combining Therapeutic Drug Monitoring and Pharmacokinetic Modelling Deconvolutes Physiological and Environmental Sources of Variability in Clozapine Exposure
Kenneth H Wills, Stephen J Behan, Michael J Nance, et al.
International Journal of Cancer
|
March 13, 2025
Evaluation of hyperprogressive disease with atezolizumab plus bevacizumab for hepatocellular carcinoma: A secondary analysis of the IMbrave150 trial
Yuan Gao, Ann-Lii Cheng, Lee X Li, et al.
British Journal of Cancer
|
October 29, 2021
Efficacy of first-line atezolizumab combination therapy in patients with non-small cell lung cancer receiving proton pump inhibitors: post hoc analysis of IMpower150
Ashley M Hopkins, Ganessan Kichenadasse, Ross A McKinnon, et al.
Epidemiology (Cambridge, Mass.)
|
January 24, 2002
Reliability of reporting on life-style and agricultural factors by a sample of participants in the Agricultural Health Study from Iowa
Aaron Blair, Robert Tarone, Dale Sandler, et al.
BMC Cancer
|
March 26, 2024
A lack of association between BMI and chemoimmunotherapy efficacy in advanced non-small cell lung cancer: Secondary analysis of the IMpower150 and IMpower130 clinical trials
Lee X Li, Mark A Socinski, Ganessan Kichenadasse, et al.
Frontiers in Oncology
|
August 8, 2020
The Influence of Pre-Existing Beta-Blockers Use on Survival Outcomes in HER2 Positive Advanced Breast Cancer: Pooled Analysis of Clinical Trial Data
Natansh D Modi, Jin Quan Eugene Tan, Andrew Rowland, et al.
JNCI Cancer Spectrum
|
January 8, 2026
Heterogeneous Treatment Effect of Immune Checkpoint inhibitors by Pre-treatment Prognosis in Randomised Controlled Trials
Lee X Li, Adel Shahnam, Ganessan Kichenadasse, et al.
Birth Defects Research. Part B, Developmental and Reproductive Toxicology
|
August 30, 2005
NTP-CERHR Expert Panel Report on the reproductive and developmental toxicity of methylphenidate
Mari Golub, Lucio Costa, Kevin Crofton, et al.
Birth Defects Research. Part B, Developmental and Reproductive Toxicology
|
September 17, 2005
NTP-CERHR Expert Panel Report on the reproductive and developmental toxicity of amphetamine and methamphetamine
Mari Golub, Lucio Costa, Kevin Crofton, et al.
Page
of 19
Search research articles
Search
Showing results (151-160 of 184) with videos related to
Sort By:
Page
of 19
British Journal of Clinical Pharmacology
|
December 2, 2017
Prediction of olanzapine exposure in individual patients using physiologically based pharmacokinetic modelling and simulation
Thomas M Polasek, Geoffrey T Tucker, Michael J Sorich, et al.
Pharmaceutics
|
January 21, 2022
Combining Therapeutic Drug Monitoring and Pharmacokinetic Modelling Deconvolutes Physiological and Environmental Sources of Variability in Clozapine Exposure
Kenneth H Wills, Stephen J Behan, Michael J Nance, et al.
International Journal of Cancer
|
March 13, 2025
Evaluation of hyperprogressive disease with atezolizumab plus bevacizumab for hepatocellular carcinoma: A secondary analysis of the IMbrave150 trial
Yuan Gao, Ann-Lii Cheng, Lee X Li, et al.
British Journal of Cancer
|
October 29, 2021
Efficacy of first-line atezolizumab combination therapy in patients with non-small cell lung cancer receiving proton pump inhibitors: post hoc analysis of IMpower150
Ashley M Hopkins, Ganessan Kichenadasse, Ross A McKinnon, et al.
Epidemiology (Cambridge, Mass.)
|
January 24, 2002
Reliability of reporting on life-style and agricultural factors by a sample of participants in the Agricultural Health Study from Iowa
Aaron Blair, Robert Tarone, Dale Sandler, et al.
BMC Cancer
|
March 26, 2024
A lack of association between BMI and chemoimmunotherapy efficacy in advanced non-small cell lung cancer: Secondary analysis of the IMpower150 and IMpower130 clinical trials
Lee X Li, Mark A Socinski, Ganessan Kichenadasse, et al.
Frontiers in Oncology
|
August 8, 2020
The Influence of Pre-Existing Beta-Blockers Use on Survival Outcomes in HER2 Positive Advanced Breast Cancer: Pooled Analysis of Clinical Trial Data
Natansh D Modi, Jin Quan Eugene Tan, Andrew Rowland, et al.
JNCI Cancer Spectrum
|
January 8, 2026
Heterogeneous Treatment Effect of Immune Checkpoint inhibitors by Pre-treatment Prognosis in Randomised Controlled Trials
Lee X Li, Adel Shahnam, Ganessan Kichenadasse, et al.
Birth Defects Research. Part B, Developmental and Reproductive Toxicology
|
August 30, 2005
NTP-CERHR Expert Panel Report on the reproductive and developmental toxicity of methylphenidate
Mari Golub, Lucio Costa, Kevin Crofton, et al.
Birth Defects Research. Part B, Developmental and Reproductive Toxicology
|
September 17, 2005
NTP-CERHR Expert Panel Report on the reproductive and developmental toxicity of amphetamine and methamphetamine
Mari Golub, Lucio Costa, Kevin Crofton, et al.
Page
of 19